Covation Biomaterials Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 1

Covation Biomaterials General Information

Description

Manufacturer of biomaterials intended to enable high-performance bio-based products at a global scale. The company offers sustainable fabrics for the textile industry, plant-based building blocks of organic chemistry a petroleum replacement for footwear to outdoor apparel, coatings, inks and functional fluids as well as biodegradable materials for personal and home care, pharmaceuticals, enhancing flavors and foods, enabling manufacturers to be sustainable without compromising on quality.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 800 Prides Crossing
  • Suite 201
  • Newark, DE
  • United States
Primary Industry
Other Chemicals and Gases
Other Industries
Other Commercial Products
Parent Company
Vertical(s)
Corporate Office
  • 800 Prides Crossing
  • Suite 201
  • Newark, DE
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covation Biomaterials Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covation Biomaterials‘s full profile, request access.

Request a free trial

Covation Biomaterials Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Covation Biomaterials‘s full profile, request access.

Request a free trial

Covation Biomaterials Acquisitions (1)

Covation Biomaterials’s most recent deal was a Merger/Acquisition with Primient Covation. The deal was made on 01-Jun-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Primient Covation 01-Jun-2022 Merger/Acquisition Specialty Chemicals
To view Covation Biomaterials’s complete acquisitions history, request access »

Covation Biomaterials Exits (1)

Covation Biomaterials’s most recent exit was on 01-Jun-2022 from Primient Covation. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Primient Covation 01-Jun-2022 Completed
To view Covation Biomaterials’s complete exits history, request access »

Covation Biomaterials FAQs

  • Where is Covation Biomaterials headquartered?

    Covation Biomaterials is headquartered in Newark, DE.

  • What industry is Covation Biomaterials in?

    Covation Biomaterials’s primary industry is Other Chemicals and Gases.

  • Is Covation Biomaterials a private or public company?

    Covation Biomaterials is a Private company.

  • What is the current valuation of Covation Biomaterials?

    The current valuation of Covation Biomaterials is .

  • What is Covation Biomaterials’s current revenue?

    The current revenue for Covation Biomaterials is .

  • Who are Covation Biomaterials’s investors?

    DuPont de Nemours has invested in Covation Biomaterials.

  • When was Covation Biomaterials acquired?

    Covation Biomaterials was acquired on 31-May-2022.

  • Who acquired Covation Biomaterials?

    Covation Biomaterials was acquired by Huafon Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process